ESC 365 - Defining arrhythmogenic cardiomyopathy in the genetic era.

ESC Premium Access

Defining arrhythmogenic cardiomyopathy in the genetic era.

Session: The Future of Personalised Medicine in Cardiomyopathy

Topic: Pharmacology and Pharmacotherapy, Other

Speaker: Doctor A. Anastasakis (Athens, GR)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Aris Anastasakis

Onassis Cardiac Surgery Center, Athens (Greece)

3 presentations

0 follower

2 more presentations in this session

Targeted therapies in hypertrophic cardiomyopathy.

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES)

Cardiomyopathy in children: a different disease?

Speaker: Professor S. Mital (Toronto, CA)

Access the full session

The Future of Personalised Medicine in Cardiomyopathy

Speakers: Doctor A. Anastasakis, Doctor P. Garcia-Pavia, Professor S. Mital

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources